📣 VC round data is live. Check it out!

Ludwig Enterprises Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ludwig Enterprises and similar public comparables like 2cureX, Kontigo Care, Induct, Aino Health and more.

Ludwig Enterprises Overview

About Ludwig Enterprises

Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.


Founded

1988

HQ

United States

Employees

3

Financials (FY)

Revenue: -
Net Income: -

EV

$7M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ludwig Enterprises Stock Performance

Ludwig Enterprises has current market cap of $5M, and enterprise value of $7M.

Market Cap Evolution


Ludwig Enterprises' stock price is $0.03.

Ludwig Enterprises share price decreased by 67.9% in the last year.

See more trading valuation data for Ludwig Enterprises
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$7M$5M0.0%--32.1%-67.9%-

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ludwig Enterprises Valuation Multiples

Ludwig Enterprises Financial Valuation Multiples

As of June 3, 2026, Ludwig Enterprises has market cap of $5M and EV of $7M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ludwig Enterprises Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Ludwig Enterprises Competitors

Ludwig Enterprises competitors include 2cureX, Kontigo Care, Induct, Aino Health, Lifeline Biotechnologies, Telemedycyna Polska, Monsenso, Diagonal Bio, Integragen and Epigenomics.

Most Ludwig Enterprises public comparables operate across Diagnostics & Genomics, Health Data & Analytics, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
2cureX--(8.6x)-
Kontigo Care1.3x-10.1x-
Induct4.0x-8.1x-
Aino Health1.2x-(12.9x)-
Lifeline Biotechnologies----
Telemedycyna Polska1.9x-(8.8x)-
Monsenso2.0x-(6.0x)-
Diagonal Bio----

This data is available for Pro users. Sign up to see all Ludwig Enterprises competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ludwig Enterprises

When was Ludwig Enterprises founded?Ludwig Enterprises was founded in 1988.
Where is Ludwig Enterprises headquartered?Ludwig Enterprises is headquartered in United States.
How many employees does Ludwig Enterprises have?As of today, Ludwig Enterprises has over 3 employees.
Is Ludwig Enterprises publicly listed?Yes, Ludwig Enterprises is a public company listed on OTC Pink Sheets.
What is the stock symbol of Ludwig Enterprises?Ludwig Enterprises trades under LUDG ticker.
When did Ludwig Enterprises go public?Ludwig Enterprises went public in 2007.
Who are competitors of Ludwig Enterprises?Ludwig Enterprises main competitors include 2cureX, Kontigo Care, Induct, Aino Health, Lifeline Biotechnologies, Telemedycyna Polska, Monsenso, Diagonal Bio, Integragen, Epigenomics.
What is the current market cap of Ludwig Enterprises?Ludwig Enterprises' current market cap is $5M.
Is Ludwig Enterprises profitable?No, Ludwig Enterprises is not profitable.
How many companies Ludwig Enterprises has acquired to date?Ludwig Enterprises hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Ludwig Enterprises has invested to date?Ludwig Enterprises hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ludwig Enterprises

Lists including Ludwig Enterprises

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial